InsidersTradesSigma
Track the 메지온 share price and the full management transaction log of the company, a listed equity based in South Korea. Shares are quoted on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 메지온 has recorded 1 public disclosures. Market capitalisation: €1,984.6bn. The latest transaction was reported on 18 March 2026 (Purchase). Among the most active insiders: 노성일. The full history is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
메지온 is a healthcare and pharmaceutical company listed on the XKRX market. It specializes in the development of innovative treatments for various diseases.